DK419487D0 - Kombinationspraeparat til thrombosebehandling indeholdende et fibrinolytum og en prostacyklinanalog - Google Patents

Kombinationspraeparat til thrombosebehandling indeholdende et fibrinolytum og en prostacyklinanalog

Info

Publication number
DK419487D0
DK419487D0 DK419487A DK419487A DK419487D0 DK 419487 D0 DK419487 D0 DK 419487D0 DK 419487 A DK419487 A DK 419487A DK 419487 A DK419487 A DK 419487A DK 419487 D0 DK419487 D0 DK 419487D0
Authority
DK
Denmark
Prior art keywords
prostacycline
analogue
fibrinolytum
thrombose
combination preparation
Prior art date
Application number
DK419487A
Other languages
English (en)
Other versions
DK419487A (da
Inventor
Berthold Baldus
Bernhard Maass
Bernd Mueller
Werner Witt
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of DK419487D0 publication Critical patent/DK419487D0/da
Publication of DK419487A publication Critical patent/DK419487A/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46Hydrolases (3)
    • A61K38/48Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/49Urokinase; Tissue plasminogen activator
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK419487A 1985-12-13 1987-08-12 Kombinationspraeparat til thrombosebehandling indeholdende et fibrinolytum og en prostacyklinanalog DK419487A (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19853544663 DE3544663A1 (de) 1985-12-13 1985-12-13 Thrombosebehandlung mit fibrinolytika und prostacyclinen
PCT/DE1986/000516 WO1987003488A1 (en) 1985-12-13 1986-12-15 Treatment of thrombosis with fibrinolytic agents and prostacyclines

Publications (2)

Publication Number Publication Date
DK419487D0 true DK419487D0 (da) 1987-08-12
DK419487A DK419487A (da) 1987-08-12

Family

ID=6288681

Family Applications (1)

Application Number Title Priority Date Filing Date
DK419487A DK419487A (da) 1985-12-13 1987-08-12 Kombinationspraeparat til thrombosebehandling indeholdende et fibrinolytum og en prostacyklinanalog

Country Status (14)

Country Link
US (1) US5316766A (da)
EP (1) EP0228988B1 (da)
JP (1) JPH0764748B2 (da)
AT (1) ATE104151T1 (da)
AU (1) AU610058B2 (da)
CA (1) CA1283357C (da)
DE (2) DE3544663A1 (da)
DK (1) DK419487A (da)
ES (1) ES2051695T3 (da)
HU (1) HU206183B (da)
IE (1) IE64462B1 (da)
IL (1) IL80900A (da)
WO (1) WO1987003488A1 (da)
ZA (1) ZA869399B (da)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6001355A (en) * 1982-12-14 1999-12-14 Dowdle; Eugene Bernard Davey Pro-tPA for the treatment of thrombosis, embolism and related conditions
GB8619098D0 (en) * 1986-08-05 1986-09-17 Wellcome Found Combination
NZ221977A (en) * 1986-10-09 1991-03-26 Smithkline Beckman Corp Thrombolytic composition comprising a plasminogen activator (tpa, uk or sk) and a thromboxane synthase inhibitor; kits thereof and process for preparation thereof
EP0299376A3 (en) * 1987-07-13 1990-01-24 William Elson Shell Prostanoid compositions and methods for reducing blood vessel dysfunction
AT402262B (de) * 1991-06-20 1997-03-25 Immuno Ag Arzneimittel enthaltend aktiviertes protein c
US6515009B1 (en) 1991-09-27 2003-02-04 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US5811447A (en) 1993-01-28 1998-09-22 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US5770609A (en) * 1993-01-28 1998-06-23 Neorx Corporation Prevention and treatment of cardiovascular pathologies
US6306421B1 (en) 1992-09-25 2001-10-23 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US6395494B1 (en) * 1993-05-13 2002-05-28 Neorx Corporation Method to determine TGF-β
US6251920B1 (en) 1993-05-13 2001-06-26 Neorx Corporation Prevention and treatment of cardiovascular pathologies
US5981568A (en) 1993-01-28 1999-11-09 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US6663881B2 (en) * 1993-01-28 2003-12-16 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US6491938B2 (en) 1993-05-13 2002-12-10 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US5595722A (en) * 1993-01-28 1997-01-21 Neorx Corporation Method for identifying an agent which increases TGF-beta levels
DE69435137D1 (de) * 1993-05-13 2008-10-16 Poniard Pharmaceuticals Inc Prävention und behandlung von pathologien, die mit einer abnormalen proliferationglatter muskelzellen verbunden sind
DE4320294A1 (de) * 1993-06-18 1994-12-22 Immuno Ag Verwendung von humanem Protein C zur Verhinderung und Behandlung von Thrombozytenablagerungen
JPH11510479A (ja) 1995-06-07 1999-09-14 ネオルックス コーポレイション タモキシフェン類似体による心臓血管疾病の予防及び治療

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5978179A (ja) * 1982-10-26 1984-05-04 Sankyo Co Ltd エポキシカルバサイクリン誘導体およびその製造法
DE3686684T2 (de) * 1985-03-06 1993-01-28 Survival Technology Mittel zur absorptionsverbesserung von proteinen.
GB8619098D0 (en) * 1986-08-05 1986-09-17 Wellcome Found Combination

Also Published As

Publication number Publication date
HUT44936A (en) 1988-05-30
HU206183B (en) 1992-09-28
ZA869399B (en) 1987-08-26
DE3689789D1 (de) 1994-05-19
WO1987003488A1 (en) 1987-06-18
AU610058B2 (en) 1991-05-16
EP0228988B1 (de) 1994-04-13
ES2051695T3 (es) 1994-07-01
EP0228988A1 (de) 1987-07-15
IE64462B1 (en) 1995-08-09
ATE104151T1 (de) 1994-04-15
JPS63501951A (ja) 1988-08-04
DK419487A (da) 1987-08-12
DE3544663A1 (de) 1987-06-19
CA1283357C (en) 1991-04-23
US5316766A (en) 1994-05-31
AU6772387A (en) 1987-06-30
IL80900A0 (en) 1987-03-31
IE863249L (en) 1987-06-13
JPH0764748B2 (ja) 1995-07-12
IL80900A (en) 1991-11-21

Similar Documents

Publication Publication Date Title
DK419487A (da) Kombinationspraeparat til thrombosebehandling indeholdende et fibrinolytum og en prostacyklinanalog
NO863560L (no) Dentalartikler og silanol-grunningsopploesning for bruk paa slike artikler.
DK393384D0 (da) Katode og apparat til katodeforstoevning
DK531885D0 (da) Fremgangsmaade til desinfektion og middel dertil
ATE78514T1 (de) Fibrinolytisches agens.
DE3882491D1 (de) Bodenstabilisierendes pulverartiges produkt und verwendungsmethode.
NO901141L (no) Additiv og fremgangsmaate for behandling av underjordiske formasjoner.
ATE38036T1 (de) Benzothiophenderivate als bronchodilatoren.
NO854945L (no) Fremgangsmaate for desinfeksjon av jordolje og jordoljeprodukter.
NO169928C (no) Fremgangsmaate og anordning for sammenfoeyning av profilseksjoner
ZA857721B (en) Process for treatment of rheumatic diseases
NO881713D0 (no) Fremgangsmaate for fremstilling av di-t-butylfenyl-alkyl og benzylethere.
NO882336L (no) Fremgangsmaate for fremstilling av 5-metoksyalkylammoniun-tetrahydrofuraner og tetrahydrotiofener.
NO874619D0 (no) Utstyr og redskap for posisjonering av installasjoner til havbunn ogfremgangsmaate.
DK162779C (da) Indretning og fremgangsmaade til antikorrosionsbehandling
NO882674L (no) Fremgangsmaate for reduksjon av karbamatinnholdet av produkter fremstilt av cellulosekarbamat og produkter fremstiltved fremgangsmaaten.
NO884818D0 (no) Fremgangsmaate og mellomprodukter for fremstilling av halogenerte proteasehemmere.
NO860584L (no) Fremgangsmaate og anordning for stoeping av jern som er blitt behandlet med magnesium.
NO156895B (no) Fremgangsmaate og apparat for dosering av pulverformige materialer.
IE881991L (en) Homocyclostatine and cyclostatine containing polypeptides as¹antihypertensive agents
NO854925L (no) Fremgangsmaate for fremstilling av akrylamid og n-substituerte akrylamider.
NO861083L (no) Analogifremgangsmaate og fremstilling av imidazoisokinoliner og imidazo-tienopyridin-forbindelser.
NO901421D0 (no) Intranasal administrering av fysostigmin og arecolin.
DK564188D0 (da) Fremgangsmaade og anlaeg til kompostering
GB8729067D0 (en) Treatment of timber

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment